The SLR presso says it all. Expensive equity being used to fund a cheap stock.It makes you laugh how ASIC just sit there and let such blatant insider trading continue
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025